Fredun Pharmaceuticals Ltd
Fredun Pharma | 539730
Share Price Chart - Fredun Pharmaceuticals Ltd
Stock Performance
Ratios
About Company
- Incorporated in 1987 as a Private Limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a Public limited company in Mar
- The Company was promoted by Nariman Medhora and Daulat N Medhora
- The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations
- Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL
- The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy
- The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products
- It supplies finished formulations to over 42 Countries globally
- It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems
- The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments
- It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Fredun Pharmaceuticals Ltd?
The current share price of Fredun Pharmaceuticals Ltd (Fredun Pharma) is ₹2583.35. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Fredun Pharmaceuticals Ltd?
The Price-to-Earnings (P/E) ratio of Fredun Pharmaceuticals Ltd is 2583.35. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd has a 52-week high of ₹2891.00 and a 52-week low of ₹820.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd offers a dividend yield of 0.03%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Fredun Pharmaceuticals Ltd?
The Earnings Per Share (EPS) of Fredun Pharmaceuticals Ltd is ₹59.17. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd has a Return on Equity (ROE) of 15.81%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
